AGIO:NASDAQ
Agios Pharmaceuticals Inc
$31.59
arrow_downward
-0.54%(-0.17) 1D
Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
$31.64
High
$31.97
Low
$30.81
Mkt. cap
1.89B
Avg. vol.
1.25M
Volume
371.34K
52-wk high
$45.99
52-wk low
$22.24
EPS
-$6.32
Beta
0.66
Shares outstanding
59.81M
No. of employees
540
Open
$31.64
High
$31.97
Low
$30.81
Mkt. cap
1.89B
Avg. vol.
1.25M
Volume
371.34K
52-wk high
$45.99
52-wk low
$22.24
EPS
-$6.32
Beta
0.66
Shares outstanding
59.81M
No. of employees
540
News stories
From web sources and news partners
Benzinga
·
1 hour ago
Dow Jones, Nasdaq 100, and S&P 500 Outlooks: Key Stock Market News This Week
RealMoney Pro
·
32 minutes ago
The Week Ahead – Have We Seen the Q4 Bottom?
Longbridge
·
2 days ago
[Weekly Recap] CTA Net Position Hits Extreme Low, Nasdaq…
The Motley Fool
·
3 hours ago
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc